Ann Lee - Net Worth and Insider Trading

Ann Lee Net Worth

The estimated net worth of Ann Lee is at least $138,259 dollars as of 2024-05-27. Ann Lee is the Director of Coya Therapeutics Inc and owns about 17,479 shares of Coya Therapeutics Inc (COYA) stock worth over $138,259. Details can be seen in Ann Lee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ann Lee has not made any transactions after 2023-08-22 and currently still holds the listed stock(s).

Transaction Summary of Ann Lee

To

Ann Lee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ann Lee owns 1 companies in total, including Coya Therapeutics Inc (COYA) .

Click here to see the complete history of Ann Lee’s form 4 insider trades.

Insider Ownership Summary of Ann Lee

Ticker Comapny Transaction Date Type of Owner
COYA Coya Therapeutics Inc 2023-08-22 director

Ann Lee Latest Holdings Summary

Ann Lee currently owns a total of 1 stock. Ann Lee owns 17,479 shares of Coya Therapeutics Inc (COYA) as of August 22, 2023, with a value of $138,259.

Latest Holdings of Ann Lee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COYA Coya Therapeutics Inc 2023-08-22 17,479 7.91 138,259

Holding Weightings of Ann Lee


Ann Lee Form 4 Trading Tracker

According to the SEC Form 4 filings, Ann Lee has made a total of 2 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 1,000 shares on August 22, 2023, which cost Ann Lee around $3,620.

Insider Trading History of Ann Lee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ann Lee Trading Performance

GuruFocus tracks the stock performance after each of Ann Lee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ann Lee is 15.35%. GuruFocus also compares Ann Lee's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ann Lee within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ann Lee's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ann Lee

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.17
Relative Return to S&P 500(%) -3.15

Ann Lee Ownership Network

Ownership Network List of Ann Lee

No Data

Ownership Network Relation of Ann Lee


Ann Lee Owned Company Details

What does Coya Therapeutics Inc do?

Who are the key executives at Coya Therapeutics Inc?

Ann Lee is the director of Coya Therapeutics Inc. Other key executives at Coya Therapeutics Inc include Chief Medical Officer Fred Grossman , Chief Medical Officer Adrian Hepner , and Chief Financial Officer David S Snyder .

Coya Therapeutics Inc (COYA) Insider Trades Summary

Over the past 18 months, Ann Lee made 2 insider transaction in Coya Therapeutics Inc (COYA) with a net purchase of 11,000. Other recent insider transactions involving Coya Therapeutics Inc (COYA) include a net purchase of 10,000 shares made by Goldstein Dov A Md , a net purchase of 10,000 shares made by Anabella Villalobos , and a net purchase of 10,000 shares made by Howard Berman .

In summary, during the past 3 months, insiders sold 0 shares of Coya Therapeutics Inc (COYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Coya Therapeutics Inc (COYA) were sold and 60,000 shares were bought by its insiders, resulting in a net purchase of 60,000 shares.

Coya Therapeutics Inc (COYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Coya Therapeutics Inc Insider Transactions

No Available Data

Ann Lee Mailing Address

Above is the net worth, insider trading, and ownership report for Ann Lee. You might contact Ann Lee via mailing address: C/o Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston Tx 77057.

Discussions on Ann Lee

No discussions yet.